Lemtrada Can Cause An Arterial Dissection and Instant Death

Lemtrada Stroke Lawsuit News

Lemtrada patients should study the risks of arterial dissection

Wednesday, January 20, 2021 - Doctors advise their patients that relapse-remitting multiple sclerosis (RRMS) is not life-threatening and is a disease one dies with, not from, however, that is not always true. RRMS sufferers have died from taking the disease-modifying therapy Lemtrada. Lemtrada is highly effective in controlling the advanced symptoms of RRMS. Lemtrada toxicity causes arterial dissection, a condition that can lead to blood clots and instant death from a heart attack or stroke. Lemtrada Stroke lawsuits handled by top national attorneys and offering a no obligation, free consultation to families and people with Lemtrada side effects.

Lemtrada is a last-resort disease-modifying therapy (DMT) used by patients with advanced relapse-remitting multiple sclerosis (RRMS). The truth about the drug would be incomplete without focusing on the high death rate of Lemtrada patients. Lemtrada can destroy the smooth lining of the arteries, causing blood to stick to the inner walls. Blood clots could develop that could break free and cause a heart attack or stroke. An article published in Multiple Sclerosis News Today (MSNT) recently focused on the mortality rate of Lemtrada patients and found that it was higher than previously assumed. MSNT writes: "Treatment with Lemtrada (alemtuzumab) is associated with the death of patients with relapsing-remitting multiple sclerosis (RRMS) more often than previously reported and appears to be most common during the first month, according to a European review." Patients with RRMS should visit Multiple Sclerosis News Today, the leading source for topical information about this insidious disease.

John Hopkins Hospital describes an arterial dissection as a sudden, devastating, life-threatening condition. According to the website, "Arterial dissection refers to the abnormal, and usually abrupt, the formation of a tear along the inside wall of an artery. As the tear becomes larger, it forms a small pouch which is called a "false lumen. The blood that accumulates inside this false lumen can generate blood clots or otherwise block blood flow, leading to a stroke. The carotid and vertebral arteries can be damaged by neck injuries or even forceful neck movements." RRMS patients that undergo Lemtrada treatments must do so in a hospital with an active and well-staffed emergency room. Doctors and nurses must monitor the patient and look for the signs an arterial dissection has occurred. Hopkins lists the early warning signs to watch for as "a droopy eyelid with a small pupil on the same side, headache, neck pain, or stroke symptoms." Stroke symptoms include facial and limb paralysis and the inability to hold the head upright and also slurred speech and the inability to focus the eyes.

The risk of an arterial dissection occurring instantly when taking Lemtrada is very real and should be carefully considered by the patient and doctor. Medical authorities at the FDA require that patient and doctor discuss the risk of arterial dissection and complete a patient-doctor questionnaire which must be signed by all parties. Lemtrada is effective in limiting the frequency and duration of RRMS seizures but could come at the ultimate price of costing the patient their lives. Many have died and their surviving love ones have consulted with Lemtrada stroke lawyers to see if they qualify to file a claim.

More Recent Lemtrada Stroke Lawsuit News:

No-Cost, No-Obligation Lemtrada Lawsuit Case Review If You or a Loved One Suffered from Lemtrada Stroke Complications

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.